- Home
- HROW vs SGHC Comparison
HROW vs SGHC Comparison
Compare HROW & SGHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HROW | SGHC |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | Guernsey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 5.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HROW | SGHC |
|---|---|---|
| Price | $46.10 | $11.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $68.86 | $16.00 |
| AVG Volume (30 Days) | 531.4K | ★ 2.5M |
| Earning Date | 11-10-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | N/A | ★ 4925.62 |
| EPS | N/A | ★ 0.45 |
| Revenue | $250,042,000.00 | ★ $2,342,912,011.00 |
| Revenue This Year | $39.05 | $27.17 |
| Revenue Next Year | $40.48 | $10.88 |
| P/E Ratio | ★ N/A | $26.25 |
| Revenue Growth | ★ 47.83 | 34.94 |
| 52 Week Low | $20.85 | $5.45 |
| 52 Week High | $51.30 | $14.38 |
Technical Indicators
Market Signals| Indicator | HROW | SGHC |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 54.61 |
| Support Level | $44.19 | $11.21 |
| Resistance Level | $47.44 | $12.06 |
| Average True Range (ATR) | 2.68 | 0.43 |
| MACD | -0.24 | 0.10 |
| Stochastic Oscillator | 55.95 | 84.88 |
Price Performance
Historical ComparisonAbout HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.